NCT07152717 Assessing Connected-Health, Pressure-Monitoring Technology for Improving Compression Therapy in Venous Leg Ulcer Treatment
| NCT ID | NCT07152717 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Feeltect Limited |
| Condition | Venous Leg Ulcers (VLUs) |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-11-06 |
| Primary Completion | 2027-01-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-11-06 with a primary completion date of 2027-01-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study evaluates the effectiveness of a connected-health, pressure monitoring technology (Tight Alright) to improve clinical outcomes of compression therapy in patients with venous leg ulcers (VLUs). Compression therapy is the standard of care for VLUs, but achieving and maintaining therapeutic sub-bandage pressure is challenging due to patient variability and lack of objective feedback. The Tight Alright system includes a wearable device that measures sub-bandage pressure at multiple points on the leg and transmits data to a mobile app and cloud database, enabling both guided compression application at the point-of-care and guided compression maintenance via remote monitoring. The study will be conducted at Parkview Noble Center for Wound Healing and will include two cohorts: a control group receiving standard unguided compression therapy with blinded device use (i.e. compression pressures will be blinded at the point of care but monitored remotely), and an intervention group using Tight Alright technology to guide compression application and reapplication. Outcomes will include wound healing rates, time to healing, pressure maintenance, patient adherence, and usability. The study aims to determine whether integrating connected-health pressure monitoring can improve consistency of compression therapy, accelerate healing, and enhance patient engagement in the treatment of venous leg ulcers
Eligibility Criteria
Inclusion Criteria: * Patient of Parkview Noble Center for Wound Healing * Adults 18+ with venous leg ulcers receiving compression therapy treatment prescribed by outpatient wound clinic. * Capable of using use a smart device * Owns a smart phone or device capable of downloading the Mobile App Exclusion Criteria: * \<18 years old * Unable to consent in English * Cellulitis in affected limb * Acute deep vein thrombosis in affected limb * Active malignancy in affected limb * Prisoners * Currently enrolled in or has been enrolled in another investigation device or drug trial in the last 30 days
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07152717 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Venous Leg Ulcers (VLUs). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07152717 currently recruiting?
Yes, NCT07152717 is actively recruiting participants. Contact the research team at Brooke.randol@parkview.com for enrollment information.
Where is the NCT07152717 trial being conducted?
This trial is being conducted at Fort Wayne, United States.
Who is sponsoring the NCT07152717 clinical trial?
NCT07152717 is sponsored by Feeltect Limited. The trial plans to enroll 40 participants.